Sentient Synthetics

AI-based Digital Pathology Solutions

Health Tech & Life Sciences
Active
Pre-Seed Herzliya Founded 2021
Total raised
$250K
Last: Pre-Seed 2021-09
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

Sentient Synthetics is an AI-based, digital pathology company leveraging machine learning to create synthetic pathology datasets for the purpose of overcoming existing data limitations in the field of computational pathology. These synthetic datasets are validated, affordable, thoroughly labeled, and free from privacy concerns. They aim to enable faster and more accurate training and validation for highly accurate AI algorithms by medical research centers, digital health, pharmaceutical companies, and diagnostics, for all cancer tissue types, including the rarer forms. Sentient is a Technion spin-off company.

Funding history · 1 round · $250K total

2021-09
Pre-Seed $250K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Enterprise & Professional ServicesHealthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Tags

enterprise-solutionssynthetic-datadiagnosticspharma-companiessoftware-platformhealthcare-providersmachine-learningartificial-intelligencedigital-healthcarecancer